ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 616348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 616348; 2) Community: the network communities that were significantly associated with the response to NSC 616348; 3) Molecule: the relationships between components within communities and NSC 616348; 4) MDR: the compounds that were significantly associated with the NSC 616348.

NSC Compound Enrichment Correlation
NSC 646847 Bengamide G 0.00863223795880985 0.44047731
NSC 647117 Null 0.00863223795880985 0.25033989
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.00863223795880985 0.59852288
NSC 667545 Null 0.00863223795880985 0.35752137
NSC 670664 Null 0.00863223795880985 -0.028091956
NSC 676372 Null 0.00863223795880985 0.092423595
NSC 681636 Camptothecin Derivative 0.00863223795880985 0.83230144
NSC 681645 Camptothecin Derivative 0.00863223795880985 0.83957772
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.00863223795880985 0.289033
NSC 686940 Null 0.00863223795880985 0.011644003
Total:98  Current:22    [First] [Prev] [Next] [Last]